Aβ1-42 aggregation inhibitor 1 is used in research for Alzheimer's disease; it inhibits acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) with IC50 values of 2.64 μM and 1.29 μM, respectively, and acts as a self-mediated inhibitor of Aβ1-42 aggregation, showing 51.29% inhibition at 25 μM.